The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Immunogenicity of melanoma‐associated gangliosides in cancer patients
Abstract
The immunogenicity of gangliosides found on human melanoma cells was determined from sera of 26 melanoma patients who were immunized every 1–4 weeks for 4 months with tumor‐cell vaccine (TCV) prepared from cultured melanoma cells. Total lipidbound sialic acid in the gangliosides isolated from TCV was 0.38 μmol/10 8 cells, and was distributed as follows: 44.8% to GM3, 44.2% to GD3, 5.6% to GM2, and 4.6% to GD2. Sera were tested at monthly intervals for antibodies to each ganglioside by ELISA with purified gangliosides as the antigen source. The immunologic specificity of the antibody was confirmed by absorption tests. None of the 26 patients had detectable anti‐GM3, anti‐GD3, or anti‐GD2 antibodies before immunization, although anti‐GM2 antibody was detected in 3 patients. After immunization, 2 patients developed IgM anti‐GD2, 10 developed IgM anti‐GM2, and 2 developed IgG anti‐GM2 antibodies. No patient developed detectable anti‐GM3 or anti‐GD3 antibodies. These results indicate that both GD2 and GM2 expressed on human melanoma cells are immunogenic in humans, although GM2 appears to be more immunogenic. The other two gangliosides, GM3 and GD3, are present in human sera and in human normal tissues, and thus immunologic tolerance may have been established against these gangliosides. Alternatively, circulating GM3 and GD3 may have neutralized anti‐GM3 and anti‐GD3 antibodies, if any were induced by TCV immunization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lingwood, C. A., & Hakomori, S. (1977) · Experimental Cell Research · doi:10.1016/s0014-4827(77)80045-1 · Cited by 58
Cited by
Livingston, P. O., Wong, G. Y., Adluri, S., Tao, Y., Padavan, M., Parente, R., Hanlon, C., Calves, M. J., Helling, F., & Ritter, G. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.1036 · Cited by 516
Chapman, P. B., Wu, D., Ragupathi, G., Lu, S., Williams, L., Hwu, W.-J., Johnson, D., & Livingston, P. O. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0345 · Cited by 70
Metadata
- Authors
- Tai, T., Cahan, L. D., Tsuchida, T., Saxton, R. E., Irie, R. F., & Morton, D. L.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1985-05-15
- Volume
- 35
- Issue
- 5
- Pages
- 607-612
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2068920805
- Cited by
- 166
- References
- 1
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunogenicity of melanoma‐associated gangliosides in cancer patients. https://app.cochat.ai/papers/10.1002/ijc.2910350507
- The paper
- Tai, T., Cahan, L. D., Tsuchida, T., Saxton, R. E., Irie, R. F., & Morton, D. L. (1985). Immunogenicity of melanoma‐associated gangliosides in cancer patients. International Journal of Cancer. https://doi.org/10.1002/ijc.2910350507
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.